Emergent biosolution stock.

Key Points. Emergent BioSolutions saw its stock plummet due to a bunch of problems in 2021. Its pipeline is unimpressive, and its services revenue isn't anything special. If its sales of over-the ...By Will Feuer . Shares of Emergent BioSolutions Inc. rose after the U.S. Food and Drug Administration said the company's overdose reversal medication Narcan could be sold over-the-counter for the first time since the opioid crisis began.Benchmark upgraded Emergent BioSolutions Inc (NYSE:EBS) from Hold To Buy with a price target of $22 on the positive FDA and Narcan market news.; Related: FDA Approves First OTC Naloxone Nasal ...Earnings: 26-Feb (Est.) Company Event: 1-Jul. EBS Stock Summary and Trading Ideas (Emergent Biosolutions ...

Shares of Emergent BioSolutions ( EBS -3.30%) were falling 4% as of 11:07 a.m. EDT on Thursday after sinking as much as 7.6% earlier in the day. The stock tumbled earlier this week after the ...Track Emergent Biosolutions Inc (EBS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

Emergent Biosolutions Inc Stock Price History. Emergent Biosolutions Inc’s price is currently down 37.08% so far this month. During the month of March, Emergent Biosolutions Inc’s stock price has reached a high of $12.54 and a low of $7.77. Over the last year, Emergent Biosolutions Inc has hit prices as high as $45.14 and as …Bought 1.3 Million shares of Emergent BioSolutions Inc: ... Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All ...

Emergent Biosolutions (EBS) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of $0.32. This compares to earnings of $4.50 per share a year ago. These figures ...EBS Stock Overview. Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States.May 10, 2022. WASHINGTON — Emergent BioSolutions, a longtime government contractor hired to produce hundreds of millions of coronavirus vaccine doses, hid evidence of quality control problems ...Emergent Biosolutions is part of the Zacks Medical - Biomedical and Genetics industry. Over the past month, Axsome Therapeutics (AXSM), a stock from the same industry, has gained 16.4%.Government contracts account for 61% of the company's sales for much of 2020. Since 2016, government agencies have stockpiled up to $6.4 billion worth of Emergent BioSolutions' products, including ...

Emergent BioSolutions reinstated with an Underweight at JPMorgan November 20, 2023TipRanks. Mixed Financial Outlook for Emergent Biosolutions: Strong Narcan Sales Offset by Lowered Guidance and ...

Feb 25, 2022 · Emergent BioSolutions (EBS-6.98%) ended the week on a down note. Shares of the company closed 6.2% lower on Friday after it provided its fourth-quarter update following the market close on Thursday.

Emergent Biosolutions Inc Stock Price History. Emergent Biosolutions Inc’s price is currently up 27.51% so far this month. During the month of April, Emergent Biosolutions Inc’s stock price has reached a high of $13.67 and a low of $9.47. Over the last year, Emergent Biosolutions Inc has hit prices as high as $43.33 and as low as $7.74.EBS - Emergent Biosolutions Inc - Stock screener for investors and traders, financial visualizations.Emergent Biosolutions Inc Stock Price History. Emergent Biosolutions Inc’s price is currently down 17.77% so far this month. During the month of March, Emergent Biosolutions Inc’s stock price has reached a high of $12.54 and a low of $7.74. Over the last year, Emergent Biosolutions Inc has hit prices as high as $44.04 and as …Robert G. Kramer Sr. to Retire. Haywood Miller to Serve as Interim CEO. GAITHERSBURG, Md., June 27, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS, “Emergent” or the “Company”) today announced that Robert G. Kramer Sr. has informed the Board of Directors of his intention to retire from Emergent. Mr.What happened. Shares of Emergent BioSolutions (EBS-4.11%) were sinking 12.8% lower as of 10:53 a.m. ET on Friday. The decline came after J.P. Morgan …The stock of Emergent Biosolutions Inc (EBS) has seen a -5.48% decrease in the past week, with a -0.75% drop in the past month, and a -51.23% fall in the past quarter. The volatility ratio for the week is 6.73%, and the volatility levels for the past 30 days are at 9.69% for EBS. The simple moving average for the last 20 days is -6.54% for …

Dec 1, 2023 · Emergent BioSolutions Awarded 10-Year BARDA Contract Valued at up to a Maximum of $704 Million for Advanced Development and Procurement of Ebanga™ Treatment for Ebola. GAITHERSBURG, Md., July 31, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it was awarded a 10-year contract by the Biomedical Advanced ... GAITHERSBURG, Md., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced NARCAN ® Naloxone HCl Nasal Spray 4 mg will be available on shelves nationwide and ...Emergent BioSolutions Inc. (NYSE: EBS) today announced that its Board of Directors has authorized management to repurchase up to $250 million of the company's common stock from time to time on the open market or in privately negotiated transactions. This repurchase authorization expires on November 11, 2022.Emergent Biosolutions is part of the Zacks Medical - Biomedical and Genetics industry. Rapt Therapeutics RAPT, another stock in the same industry, closed the last trading session 2.7% higher at ...The latest price target for Emergent BioSolutions ( NYSE: EBS) was reported by Benchmark on Tuesday, August 29, 2023. The analyst firm set a price target for 0.00 expecting EBS to fall to within ...Emergent BioSolutions Contacts: Media: Matt Hartwig Senior Director, Media Relations 240-760-0551 [email protected]. Investors: Robert G. Burrows Vice President, Investor Relations 240-631-3280 [email protected]. Source: Emergent BioSolutions

2.15 Delayed Data As of Nov 29 +0.14 / +6.97% Today’s Change 1.81 Today ||| 52-Week Range 16.66 -81.80% Year-to-Date Quote Profile News Charts Forecasts Financials Shareholders Competitors vs....10 stocks we like better than Emergent BioSolutions When o ur analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock ...

Emergent Biosolutions Inc Stock Price History. Emergent Biosolutions Inc’s price is currently down 28.43% so far this month. During the month of March, Emergent Biosolutions Inc’s stock price has reached a high of $12.54 and a low of $7.74. Over the last year, Emergent Biosolutions Inc has hit prices as high as $45.14 and as …18 thg 5, 2023 ... ... Emergent BioSolutions Inc. of its shares of common stock for up to an aggregate offering price of $150 million. The common stock is listed ...Emergent Biosolutions Inc Stock Price History. Emergent Biosolutions Inc’s price is currently down 37.08% so far this month. During the month of March, Emergent Biosolutions Inc’s stock price has reached a high of $12.54 and a low of $7.77. Over the last year, Emergent Biosolutions Inc has hit prices as high as $45.14 and as …Emergent BioSolutions stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.N/A. N/A. See Emergent BioSolutions Inc. (EBS) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Emergent BioSolutions ( EBS 11.68%) probably wishes it had stayed in bed on Tuesday. The company's stock declined by nearly 12% that day, following its release of quarterly results that fell well ...The FDA approved Emergent BioSolutions Inc's (NYSE:EBS) anthrax vaccine for adults aged 18 through 65.. The vaccine Cyfendus (Anthrax Vaccine Adsorbed, Adjuvanted), previously known as AV7909, is ...Legal Name Emergent BioSolutions Inc. Stock Symbol NYSE:EBS. Company Type For Profit. Contact Email [email protected]. Phone Number 240-631-3200. Emergent BioSolutions is a global life sciences company that is driven by a mission to protect and enhance life. It develops, manufactures, and delivers a portfolio of medical …Emergent Biosolutions is part of the Zacks Medical - Biomedical and Genetics industry. Rapt Therapeutics RAPT, another stock in the same industry, closed the last trading session 2.7% higher at ...

Emergent Biosolutions Inc Stock Price History. Emergent Biosolutions Inc’s price is currently down 17.77% so far this month. During the month of March, Emergent Biosolutions Inc’s stock price has reached a high of $12.54 and a low of $7.74. Over the last year, Emergent Biosolutions Inc has hit prices as high as $44.04 and as low as $7.74.

GAITHERSBURG, Md., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the Biomedical Advanced Research and Development Authority (BARDA) within the ...

Emergent BioSolutions: Stellar Acting Stock TraderMark Wed, Oct. 22, 2008 3 Comments. Emergent BioSolutions: Surprising Value Play Saj Karsan Fri, Sep. 12, 2008 1 Comment. 1 2 Next. People Also ...Jun 26, 2023 · Emergent BioSolutions. Market Cap. $108M. Today's Change. (%) Current Price. $2.09. Price as of November 24, 2023, 1:00 p.m. ET. You’re reading a free article with opinions that may differ from ... Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on November 2, 2023. GAITHERSBURG, Md. , Oct. 19, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, November 2, 2023 , at 5:00 pm eastern time to discuss the financial results for the.Verdict: Emergent BioSolutions lost $2.23 a share in FY2022 on revenues of $1.12 billion. The current analyst firm consensus has that loss dropping just below a buck a share in FY2023 even as ...Oct 9, 2023 · NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown. The bid-ask spread can indicate a stock’s liquidity, which is how easy it is to buy and sell in theEBS Price Action: Emergent Biosolutions has a 52-week high of $45.02 and a 52-week low of $7.74. The stock was up 18.9% at $10.59 at time of publication, according to Benzinga Pro. Photo: courtesy ...Emergent Biosolutions Inc Stock Price History. Emergent Biosolutions Inc’s price is currently down 6.14% so far this month. During the month of February, Emergent Biosolutions Inc’s stock price has reached a high of $16.66 and a low of $11.63. Over the last year, Emergent Biosolutions Inc has hit prices as high as $45.14 and as …Emergent became a publicly traded company in 2006, with its stock trading on the New York Stock Exchange under the symbol EBS. Mergers, acquisitions and joint ...Access to Narcan, a lifesaving drug that reverses overdoses, has been limited by Emergent BioSolutions’ hunt for profits, including a five-year delay in bringing it over the counter.

Get Emergent BioSolutions Inc (ebs) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.Emergent BioSolutions. Reports Q1 2023 total revenues of $165M, above the prior guidance range, net loss of $183M and adjusted EBITDA of negative $101M. Updates FY 2023 guidance and provides ...What happened. Shares of Emergent BioSolutions ( EBS -0.96%) were jumping 12% as of 11:09 a.m. ET on Monday. The big gain was due to increased concerns about the spread of monkeypox. Emergent ...Instagram:https://instagram. otcmkts tcnnf newstax rate for contractorstrading laptop computersrty future What happened. Shares of Emergent Biosolutions ( EBS -0.48%) have crashed 41.1% as of 11:44 a.m. EDT on Friday. The huge decline came after the company revealed on Thursday that a multimillion ... nyse ovvcollab student housing investment Get the latest Emergent BioSolutions Inc. (EBS) stock news and headlines to help you in your trading and investing decisions.Emergent BioSolutions Inc. has rescheduled its conference call to discuss the financial results for the third quarter of 2023, recent business deve... bil stock dividend GAITHERSBURG, Md., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced NARCAN ® Naloxone HCl Nasal Spray 4 mg will be available on shelves nationwide and ...Emergent Biosolutions shares outstanding from 2010 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including ...Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q Filing. GAITHERSBURG, Md., Nov. 24, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today confirmed that on November 16, 2023, the New York Stock Exchange (NYSE) sent a notice that the company is not in compliance with Section …